Bhutan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Bhutan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases grew 8.8% year on year. In 2019, the country was ranked number 147 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 87 Cases. India topped the ranking with 66,255 Cases in 2019, +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 87.00 |
| 2018 | 63.00 |
| 2017 | 60.00 |
| 2016 | 55.00 |
| 2015 | 49.00 |
Download all data from 2005 to 2019
How does Bhutan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 145 |
#145
Germany
|
90 | 2014 | -19.6 % | +5.2 % | View data | |
| 147 |
#147
Bhutan
|
87 | 2019 | +38.1 % | +8.8 % | View data | |
| 148 |
#148
France
|
86 | 2019 | +3.6 % | -5.0 % | View data | |